Innoviva (INVA) Accounts Payables (2010 - 2026)
Innoviva (INVA) posted Accounts Payables of $6.5 million for Q1 2026, up 31.25% on a QoQ basis from $5.0 million in Q4 2025, and up 38.68% year-over-year from $4.7 million in Q1 2025.
Innoviva (INVA) Accounts Payables (2010 - 2026) Analysis & Trends
Innoviva's Accounts Payables history runs 17 years deep, the most recent figure standing at $6.5 million for Q1 2026.
- Quarterly Accounts Payables rose 38.68% year-over-year to $6.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.5 million (up 38.68% YoY) and the FY2025 annual result came in at $5.0 million, up 132.93% from the prior year.
- Accounts Payables was $6.5 million for Q1 2026 at Innoviva, up from $5.0 million in the prior quarter.
- Across five years, Accounts Payables topped out at $6.7 million in Q4 2023 and bottomed at $890000.0 in Q1 2024.
- A 5-year average of $4.2 million and a median of $4.3 million in 2022 frame the typical range for Accounts Payables.
- Annual changes were most pronounced in 2022 — Accounts Payables surged 14310.0% — and 2024, when it tumbled 85.0%.
- Innoviva's Accounts Payables stood at $2.9 million in 2022, then jumped by 128.55% to $6.7 million in 2023, then tumbled by 68.26% to $2.1 million in 2024, then surged by 132.93% to $5.0 million in 2025, then surged by 31.25% to $6.5 million in 2026.
- Business Quant data shows INVA's Accounts Payables at $6.5 million in Q1 2026, $5.0 million in Q4 2025, and $6.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 5.74 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 10.62 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 423.55 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 694,346.76 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 489.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.03 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.52 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 80.54 Mn |
| 10 | Innoviva | 1.57 Bn | 969.11 Mn | 75.83 Mn | 6.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.52 Mn |
| Dec 31, 2025 | 4.97 Mn |
| Sep 30, 2025 | 6.24 Mn |
| Jun 30, 2025 | 5.38 Mn |
| Mar 31, 2025 | 4.70 Mn |
| Dec 31, 2024 | 2.13 Mn |
| Sep 30, 2024 | 4.17 Mn |
| Jun 30, 2024 | 2.04 Mn |
| Mar 31, 2024 | 890,000.00 |
| Dec 31, 2023 | 6.72 Mn |
| Sep 30, 2023 | 3.78 Mn |
| Jun 30, 2023 | 4.59 Mn |
| Mar 31, 2023 | 5.93 Mn |
| Dec 31, 2022 | 2.94 Mn |
| Sep 30, 2022 | 3.81 Mn |
| Jun 30, 2022 | 4.32 Mn |
| Mar 31, 2022 | 1.81 Mn |
| Dec 31, 2021 | 27,000.00 |
| Sep 30, 2021 | 89,000.00 |
| Jun 30, 2021 | 30,000.00 |